Aldeyra Therapeutics Current Ratio 2014-2019 | ALDX

Aldeyra Therapeutics current ratio from 2014 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Aldeyra Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.07B $0.01B 11.40
2019-03-31 $0.09B $0.01B 9.17
2018-12-31 $0.10B $0.01B 11.19
2018-09-30 $0.04B $0.01B 4.81
2018-06-30 $0.04B $0.01B 8.11
2018-03-31 $0.04B $0.00B 11.07
2017-12-31 $0.04B $0.00B 13.11
2017-09-30 $0.05B $0.00B 20.28
2017-06-30 $0.03B $0.00B 12.47
2017-03-31 $0.03B $0.00B 13.06
2016-12-31 $0.03B $0.00B 10.93
2016-09-30 $0.03B $0.00B 11.05
2016-06-30 $0.03B $0.00B 13.83
2016-03-31 $0.02B $0.00B 12.89
2015-12-31 $0.03B $0.00B 13.28
2015-09-30 $0.03B $0.00B 22.73
2015-06-30 $0.03B $0.00B 24.32
2015-03-31 $0.02B $0.00B 15.34
2014-12-31 $0.01B $0.00B 6.60
2014-09-30 $0.01B $0.00B 12.23
2014-06-30 $0.01B $0.00B 10.05
2014-03-31 $0.00B $0.00B 3.12
2013-12-31 $0.00B $0.00B 5.41
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.161B $0.000B
Aldeyra Therapeutics, Inc. is a biotechnology company. The company's products target immune-mediated, inflammatory, orphan, and other diseases. It is developing NS2, a compound that binds and traps free aldehydes. Aldeyra Therapeutics, Inc. is based in Burlington, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.387B 37.19
Takeda Pharmaceutical (TAK) Japan $54.643B 8.55
Astellas Pharma (ALPMY) Japan $31.264B 14.90
Merck (MKGAF) Germany $15.139B 20.66
Eisai (ESALY) Japan $14.704B 22.51
UCB SA (UCBJF) Belgium $14.373B 0.00
Grifols, S.A (GRFS) Spain $14.287B 18.23
Ono Pharmaceutical (OPHLF) Japan $9.212B 19.69
Neurocrine Biosciences (NBIX) United States $8.908B 0.00
IPSEN SA ADR (IPSEY) France $8.872B 0.00
Ionis Pharmaceuticals (IONS) United States $7.764B 16.75
Sage Therapeutics (SAGE) United States $7.279B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Catalent (CTLT) United States $7.112B 28.11
Jazz Pharmaceuticals (JAZZ) Ireland $6.855B 9.02
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.094B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Hypermarcas (HYPMY) Brazil $5.279B 18.98
Orion OYJ (ORINY) Finland $5.271B 27.14
United Therapeutics (UTHR) United States $3.685B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.461B 79.35
FibroGen (FGEN) United States $3.411B 85.30
Evotec AG (EVTCY) Germany $3.224B 44.14
Nektar Therapeutics (NKTR) United States $3.108B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.923B 10.48
PTC Therapeutics (PTCT) United States $2.246B 0.00
Tilray (TLRY) Canada $2.191B 0.00
Xencor (XNCR) United States $2.052B 44.75
Portola Pharmaceuticals (PTLA) United States $1.938B 0.00
Zogenix (ZGNX) United States $1.900B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.650B 60.04
Corcept Therapeutics (CORT) United States $1.579B 21.70
USANA Health Sciences (USNA) United States $1.556B 15.60
Heron Therapeutics (HRTX) United States $1.520B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.390B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.308B 0.00
Radius Health (RDUS) United States $1.261B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.200B 19.80
ArQule (ARQL) United States $1.146B 0.00
Endo (ENDP) Ireland $1.053B 1.85
Theravance Biopharma (TBPH) Cayman Islands $0.975B 0.00
TherapeuticsMD (TXMD) United States $0.917B 0.00
Aerie Pharmaceuticals (AERI) United States $0.900B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.885B 3.95
Spectrum Pharmaceuticals (SPPI) United States $0.883B 0.00
Dova Pharmaceuticals (DOVA) United States $0.816B 0.00
Organogenesis Holdings (ORGO) United States $0.707B 0.00
Karyopharm Therapeutics (KPTI) United States $0.690B 0.00
Concordia (CXRXF) Canada $0.588B 0.00
Flexion Therapeutics (FLXN) United States $0.571B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.561B 0.00
Akebia Therapeutics (AKBA) United States $0.493B 0.00
Indivior (INVVY) United States $0.465B 1.68
Aptorum Group (APM) Hong Kong, SAR China $0.463B 0.00
ChemoCentryx (CCXI) United States $0.463B 0.00
Lannett Co Inc (LCI) United States $0.462B 4.87
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.459B 0.00
Translate Bio (TBIO) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.444B 1.04
ImmunoGen (IMGN) United States $0.402B 0.00
Collegium Pharmaceutical (COLL) United States $0.397B 0.00
Dermira (DERM) United States $0.396B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.389B 0.00
DURECT (DRRX) United States $0.380B 0.00
Innate Pharma SA (IPHYF) France $0.369B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.348B 15.83
Corbus Pharmaceuticals Holdings (CRBP) United States $0.337B 0.00
OptiNose (OPTN) United States $0.321B 0.00
Harpoon Therapeutics (HARP) United States $0.319B 0.00
Rafael Holdings (RFL) United States $0.312B 0.00
Ardelyx (ARDX) United States $0.308B 0.00
Molecular Templates (MTEM) United States $0.307B 0.00
Recro Pharma (REPH) United States $0.294B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.282B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.265B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.235B 0.00
Xeris Pharmaceuticals (XERS) United States $0.231B 0.00
GlycoMimetics (GLYC) United States $0.221B 0.00
CV Sciences (CVSI) United States $0.208B 0.00
KalVista Pharmaceuticals (KALV) United States $0.204B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.198B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.194B 0.00
CannTrust Holdings (CTST) Canada $0.192B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 30.23
AcelRx Pharmaceuticals (ACRX) United States $0.174B 0.00
Taiwan Liposome (TLC) Taiwan $0.168B 0.00
Ocular Therapeutix (OCUL) United States $0.160B 0.00
Calithera Biosciences (CALA) United States $0.147B 0.00
Concert Pharmaceuticals (CNCE) United States $0.146B 0.00
IMV INC (IMV) Canada $0.145B 0.00
Redhill Biopharma (RDHL) Israel $0.144B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.129B 0.00
MEI Pharma (MEIP) United States $0.126B 0.00
Generex Biotechnology (GNBT) United States $0.126B 0.00
Jounce Therapeutics (JNCE) United States $0.116B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.116B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.101B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 32.35
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Aquestive Therapeutics (AQST) United States $0.080B 0.00
MediWound (MDWD) Israel $0.077B 0.00
Lipocine (LPCN) United States $0.076B 0.00
Champions Oncology (CSBR) United States $0.073B 0.00
Majesco Entertainment (PTE) United States $0.073B 0.00
Neos Therapeutics (NEOS) United States $0.072B 0.00
Otonomy (OTIC) United States $0.068B 0.00
Genocea Biosciences (GNCA) United States $0.068B 0.00
Natural Alternatives (NAII) United States $0.067B 10.11
Infinity Pharmaceuticals (INFI) United States $0.064B 0.00
AgeX Therapeutics (AGE) United States $0.064B 0.00
Melinta Therapeutics (MLNT) United States $0.063B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
IntelGenx Technologies (IGXT) Canada $0.062B 0.00
Novan (NOVN) United States $0.061B 0.00
RENEURON GP (RNUGF) United Kingdom $0.060B 0.00
Aclaris Therapeutics (ACRS) United States $0.058B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.058B 0.00
ElectroCore (ECOR) United States $0.057B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.051B 0.00
Nivalis Therapeutics (ALPN) United States $0.050B 0.00
Capnia (SLNO) United States $0.046B 0.00
CTI BioPharma (CTIC) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
India Globalization Capital (IGC) United States $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
Mast Therapeutics (SVRA) United States $0.036B 0.00
Bio-Path Holdings (BPTH) United States $0.035B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.032B 0.00
Biomerica (BMRA) United States $0.031B 0.00
PharmAthene (ALT) United States $0.030B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
IsoRay (ISR) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 16.83
Vical (BBI) United States $0.013B 0.00
Heat Biologics (HTBX) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.013B 0.00
Achieve Life Sciences (ACHV) United States $0.012B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Onconova Therapeutics (ONTX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00